Park Avenue Securities LLC bought a new position in shares of Cabot Corporation (NYSE:CBT – Free Report) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 4,162 shares of the specialty chemicals company’s stock, valued at approximately $312,000.
A number of other institutional investors and hedge funds have also recently modified their holdings of CBT. LSV Asset Management lifted its holdings in shares of Cabot by 318.0% during the first quarter. LSV Asset Management now owns 571,034 shares of the specialty chemicals company’s stock worth $47,476,000 after purchasing an additional 434,434 shares during the period. American Century Companies Inc. lifted its holdings in shares of Cabot by 13.2% during the first quarter. American Century Companies Inc. now owns 1,498,268 shares of the specialty chemicals company’s stock worth $124,566,000 after purchasing an additional 174,921 shares during the period. AQR Capital Management LLC lifted its holdings in shares of Cabot by 79.5% during the first quarter. AQR Capital Management LLC now owns 389,244 shares of the specialty chemicals company’s stock worth $31,626,000 after purchasing an additional 172,410 shares during the period. Nuveen LLC acquired a new stake in shares of Cabot during the first quarter worth about $12,365,000. Finally, GAMMA Investing LLC lifted its holdings in shares of Cabot by 10,385.0% during the first quarter. GAMMA Investing LLC now owns 141,338 shares of the specialty chemicals company’s stock worth $11,751,000 after purchasing an additional 139,990 shares during the period. Institutional investors and hedge funds own 93.18% of the company’s stock.
Insider Transactions at Cabot
In other Cabot news, CEO Sean D. Keohane sold 114,436 shares of Cabot stock in a transaction on Thursday, August 14th. The shares were sold at an average price of $79.28, for a total transaction of $9,072,486.08. Following the sale, the chief executive officer owned 361,518 shares of the company’s stock, valued at $28,661,147.04. The trade was a 24.04% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 3.03% of the company’s stock.
Cabot Price Performance
Cabot (NYSE:CBT – Get Free Report) last released its quarterly earnings results on Monday, August 4th. The specialty chemicals company reported $1.90 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.80 by $0.10. Cabot had a net margin of 11.14% and a return on equity of 25.68%. The firm had revenue of $923.00 million for the quarter, compared to analysts’ expectations of $957.29 million. Cabot has set its FY 2025 guidance at 7.150-7.500 EPS. As a group, equities research analysts anticipate that Cabot Corporation will post 7.57 earnings per share for the current fiscal year.
Cabot Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Thursday, September 11th. Investors of record on Friday, August 29th were paid a $0.45 dividend. The ex-dividend date of this dividend was Friday, August 29th. This represents a $1.80 dividend on an annualized basis and a yield of 2.4%. Cabot’s dividend payout ratio (DPR) is currently 23.53%.
Analysts Set New Price Targets
Separately, UBS Group set a $82.00 target price on Cabot and gave the stock a “neutral” rating in a report on Tuesday, August 5th. One investment analyst has rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $92.33.
View Our Latest Stock Report on Cabot
Cabot Company Profile
Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.
Read More
- Five stocks we like better than Cabot
- Breakout Stocks: What They Are and How to Identify Them
- PayPal Stock: Why Wall Street May Be Undervaluing This Giant
- Stock Sentiment Analysis: How it Works
- Why Vertical Aerospace Could Lead the eVTOL Market by 2028
- Stock Dividend Cuts Happen Are You Ready?
- Is Draganfly’s Army Partnership a Game-Changer for Investors?
Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.